PT  - JOURNAL ARTICLE
AU  - Wegrzyn, Renee D.
AU  - Appiah, Grace D.
AU  - Morfino, Robert
AU  - Milford, Scott R.
AU  - Walker, Allison Taylor
AU  - Ernst, Ezra T.
AU  - Darrow, William W.
AU  - Li, Siayo Lisa
AU  - Robison, Keith
AU  - MacCannell, Duncan
AU  - Dai, Dongjuan
AU  - Girinathan, Brintha P.
AU  - Hicks, Allison L.
AU  - Cosca, Bryan
AU  - Woronoff, Gabrielle
AU  - Plocik, Alex M.
AU  - Simen, Birgitte B.
AU  - Moriarty, Leah
AU  - Guagliardo, Sarah Anne J.
AU  - Cetron, Martin S.
AU  - Friedman, Cindy R.
TI  - Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022
AID  - 10.1101/2022.03.21.22272490
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.21.22272490
4099  - http://medrxiv.org/content/early/2022/03/22/2022.03.21.22272490.short
4100  - http://medrxiv.org/content/early/2022/03/22/2022.03.21.22272490.full
AB  - We enrolled arriving international air travelers in SARS-CoV-2 genomic surveillance, using molecular testing of pooled nasal swabs, and sequencing positive samples for viral lineage. Traveler-based genomic surveillance provided early warning variant detection; we reported the first U.S. Omicron BA.2 and first BA.3 in North America, weeks before next reported detection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the U.S. Centers for Disease Control and Prevention (CDC)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors